Plenary Speaker

Carl Dieffenbach

Carl Dieffenbach Ph.D
Director, DAIDS, NIAID
National Institutes of Health, Bethesda, MD

Title: Drug Development for HIV: We have come so far, and we are not yet done

Carl W. Dieffenbach, Ph.D., serves as Director of the Division of AIDS (DAIDS). Dr. Dieffenbach oversees a global HIV/AIDS research portfolio of more than $1 billion and a staff of more than 150 federal employees. He played a key role in restructuring the DAIDS-supported clinical trials research networks and has actively fostered collaboration and partnerships with other federal agencies, international research organizations, foundations, and industry. In 1992, he joined DAIDS as the chief of the preclinical therapeutics group. Upon his appointment, Dr. Dieffenbach spearheaded important research initiatives that accelerated the progress of basic research on HIV pathogenesis and directly resulted in new clinical studies of novel AIDS therapies. In 1996, he was promoted to Director of the DAIDS Basic Sciences Program, where he remained until being selected as the division director in 2008. In 2011, Dr. Dieffenbach received the Distinguished Alumnus Award of the Department of Chemistry and Biochemistry, University of Maryland.

Keynote Speakers

Lawrence Vernetti

Lawrence Vernetti

Director of Early Drug Safety
University of Pittsburgh, Pittsburgh, PA
Yves Pommier

Yves Pommier

Chief, Developmental Therapeutics Branch, NIH, Bethesda, MD
Ethan Russo

Ethan Russo

Director of R&D, International Cannabis and Cannabinoids Institute, Czech Republic, EU
Paul Dunman

Paul Dunman

Principal Investigator, University of Rochester Medical Center, Rochester, NY
Christine Esau

Christine Esau

Vice President of Drug Discovery at Genevant Sciences
Boston, MA
Brian Schneider

Brian Schneider

Sr. Territory Account Manager, Synthego, Redwood City, CA

Silver Sponsor




Supporting Sponsor



Symposium I: Emergent Drug Development Approaches and Opportunities
Symposium II: Emerging Drug Development for Cannabis
Symposium III: Nucleic Acids as Drugs, Drug Targets and Gene Editing Tools
Symposium IV: Drug Development for Infectious Disease and Immune Modulation
Symposium V: Oncology Drug Target Validation

Goal of the Drug Discovery-2019

The purpose of this year’s conference is to exemplify outstanding preclinical drug discovery that is being conducted globally in companies and contract research and academic laboratories. Our goal is to encourage a dialog on ideation, collaboration and resource sharing.


This conference will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of drug research. The attending experts and industry partners will also provide a fantastic networking experience.

Previous Edition

Drug Discovery-2018 brought together some 80+ presentations from leading institutes and organizations having a diverse subject expertise from more than 24 countries gathered to share and discuss on the latest scientific advances in the field of drug discovery and pharmaceutical sciences.

About Drug Discovery Conference 2019

About Us

United Scientific Group (USG) a non-profit Scientific Organization cordially invites all the participants from all over the world to attend "5 th International Conference on Drug Discovery, Development and Lead Optimization" during Nov 21-23, 2019 | Boston, MA (Drug Discovery-2019).

United Scientific Group (USG) a non-profit Scientific Organization successfully completed the First International Conference on Clinical Sciences and Drug Discovery in Baltimore, MD, USA during November 2-4, 2015 (CSDD-2015), Second Edition in Dundee, Scotland, UK during July 27-29 2016 (CSDD-2016), Third Edition in Reston, VA, USA during November 9-11, 2017 (CSDD-2017)... Read More

Scientific Topics

The conference covers hottest therapeutic areas and the latest drug development models in the pharm and Biotech industry. The subject areas may include, but are not limited to the following domains:

  • Biologics: Small Molecules, Adjuvants, Immunoassays
  • Anti-Infectives
  • Medicinal Cannabinoids
  • Disease Target Validation
  • Biomarkers & Diagnostics
  • Protein-Protein Interactions
  • CNS and Cancer Targeted Drug Discovery
  • Innovative Drug Discovery and Nanotechnology
  • High throughput Technologies and RNAi Screening
  • Chemical approaches to Drug Discovery
  • Novel Approaches to Drug Design and Development
  • Structure-Based Drug Design
  • Computer-Aided Drug Design
  • Artificial Intelligence
  • Medicinal Chemistry
  • Genomic Approaches to Drug Discovery
  • Fragment-Based Drug Discovery
  • Drug Efficacy and Toxicology

Drug Discovery Previous Speakers

  • Ferid Murad

    George Washington University
    Washington DC , USA

  • Philip S. Low

    Purdue University

  • Wendy Cornell

    IBM - Healthcare and Life Sciences Research, NY, USA

  • Troels Koch

    Roche Innovation Center Copenhagen, Denmark

  • Harold C. Smith

    University of Rochester
    NY, USA

  • Sir Philip Cohen

    University of Dundee

  • Kenneth A. Jacobson

    National Institute of Health
    MD, USA

  • Paul Wyatt

    University of Dundee

  • Thomas D.Y. Chung

    SBP Medical Discovery Institute
    CA, USA

  • Michelle Arkin

    Small Molecule Discovery Center (SMDC), CA, USA

  • Thomas Webster

    Northeastern University
    MA, USA

  • Howard Stevens

    Bio-Images Drug Delivery Ltd

  • Luke O'Neill

    The University of Dublin

  • Andrew West


  • Graham Russell

    Oxford University

About Organizer

Who We Are

United Scientific Group (USG) a non-profit Scientific Organization, an expert-driven initiative led by the editor’s association and the advisory board which includes academicians, researchers, and industry leaders across various fields of research. USG provides broad range of services in the fields of science and technology including publishing, conducting world class scientific events, and holding highly interactive and proficient world forums. For more information, please visit:

Why Choose Us?

Drug Discovery-2019 will be an invaluable resource for researchers, clinicians, healthcare professionals across different therapeutic and research areas.

  • Creative Speakers & Panel Discussions
  • Interactive Poster Session
  • Emerging Researcher Forum
  • Networking & Collaboration
  • Full-length Manuscript Submissions
  • Opportunity to organize Workshop/Symposium


  • Thanks to organising committee for such an excellent event.

    Abhishek Mashirkar, MBBS, M.D.

    Government Medical College, Nagpur, India

  • I enjoyed being part of it. I got to know two persons. A possible suggestion for future editions is the publishing of proceedings with SCOPUS index.

    Roberto Rosas Romero, Ph.D.

    Universidad de las Américas, Mexico

  • It was a really nice conference with innovative presentations . I really learnt alot and the sessions were really interesting. Thank you giving me this opportunity to present my study in a very academic and friendly environment.

    Muhammad Bilal Fayyaz, MBBS, FCPS

    SKM Cancer Hospital & Research Centre, Pakistan

Late Registrations


$ 899 $ 1099

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms


$ 949 $ 1149

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms


$ 999 $ 1199

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms


$ 399 $ 499

  • Conference material
  • Access to exhibits, poster sessions
  • Free access to conference app
  • Lunch, tea/coffee breaks
  • WiFi in meeting rooms

Subscribe to our Newsletter

Be the first to receive exclusive discounts and the latest news on our conference directly in your inbox.

Conference Venue

Contact form


USG United Scientific Group
A non-profit scientific organization
Plano, TX 75024, USA